Dolby Laboratories (Dolby Laboratories) Change In Payables And Accrued Expense

: $-90 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

Dolby Laboratories's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $-32 Mil. It means Dolby Laboratories's Accounts Payable & Accrued Expense declined by $32 Mil from Sep. 2023 to Dec. 2023 .

Dolby Laboratories's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2023 was $-52 Mil. It means Dolby Laboratories's Accounts Payable & Accrued Expense declined by $52 Mil from Sep. 2022 to Sep. 2023 .

Dolby Laboratories Change In Payables And Accrued Expense Historical Data

The historical data trend for Dolby Laboratories's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Change In Payables And Accrued Expense

33.42

-43.55

44.23

-33.54

-52.32

Dolby Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense																5.77	15.84	-105.35	31.42	-31.99

Dolby Laboratories Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-90 Mil.

Dolby Laboratories Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Dolby Laboratories (Dolby Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

FUO:Germany FUO:Germany

Address

1275 Market Street, San Francisco, CA, USA, 94103-1410

Website

https://www.dolby.com

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Executives

Kevin J Yeaman	officer: VP, Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman	officer: EVP, GEN. COUN. & SECRTY	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling	officer: SVP, Entertainment	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton	officer: SVP, Chief Marketing Officer	1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud	director	C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian	director	DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher	director
Ryan Nicholson	officer: VP, Corporate Controller	C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar	officer: SVP, Advanced Technology Group	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet	director	9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park	officer: SVP & Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay	officer: Sr. Vice President, Research	1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew	officer: EVP, Chief Financial Officer	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103